Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Clinical trial NCT02807285 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02807285
- Sponsor
- Genentech, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.